Luis Tecedor

1.5k total citations
20 papers, 1.1k citations indexed

About

Luis Tecedor is a scholar working on Molecular Biology, Physiology and Cell Biology. According to data from OpenAlex, Luis Tecedor has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Physiology and 7 papers in Cell Biology. Recurrent topics in Luis Tecedor's work include Lysosomal Storage Disorders Research (9 papers), Cellular transport and secretion (5 papers) and RNA Interference and Gene Delivery (3 papers). Luis Tecedor is often cited by papers focused on Lysosomal Storage Disorders Research (9 papers), Cellular transport and secretion (5 papers) and RNA Interference and Gene Delivery (3 papers). Luis Tecedor collaborates with scholars based in United States, Austria and Germany. Luis Tecedor's co-authors include Beverly L. Davidson, Alex Mas Monteys, Mark L. Schultz, Michael Chang, Ji Wan, Yi Xing, Ryan M. Spengler, Colleen S. Stein, Yong Hong Chen and Leslie M. Thompson and has published in prestigious journals such as Nature, Nature Communications and Neuron.

In The Last Decade

Luis Tecedor

19 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luis Tecedor United States 14 689 393 300 213 147 20 1.1k
Zofia M. Lasiecka United States 11 564 0.8× 206 0.5× 148 0.5× 367 1.7× 287 2.0× 14 968
Xiaolu A. Cambronne United States 14 990 1.4× 132 0.3× 536 1.8× 49 0.2× 137 0.9× 19 1.5k
Zen Kouchi Japan 19 632 0.9× 197 0.5× 102 0.3× 323 1.5× 97 0.7× 23 1.2k
Giorgio Rovelli Switzerland 20 746 1.1× 219 0.6× 169 0.6× 245 1.2× 418 2.8× 24 1.4k
Tiago G. Santos Brazil 19 690 1.0× 168 0.4× 61 0.2× 80 0.4× 93 0.6× 40 935
Laura Magri Italy 11 745 1.1× 168 0.4× 179 0.6× 143 0.7× 77 0.5× 12 1.0k
Heather Flanagan‐Steet United States 20 827 1.2× 240 0.6× 47 0.2× 362 1.7× 140 1.0× 41 1.2k
Chang-Hyuk Kwon United States 13 961 1.4× 163 0.4× 206 0.7× 98 0.5× 111 0.8× 20 1.3k
Anita Schlierf United States 6 535 0.8× 87 0.2× 143 0.5× 175 0.8× 137 0.9× 8 824
Sergi Simó United States 16 582 0.8× 129 0.3× 91 0.3× 352 1.7× 355 2.4× 30 1.0k

Countries citing papers authored by Luis Tecedor

Since Specialization
Citations

This map shows the geographic impact of Luis Tecedor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Tecedor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Tecedor more than expected).

Fields of papers citing papers by Luis Tecedor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis Tecedor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Tecedor. The network helps show where Luis Tecedor may publish in the future.

Co-authorship network of co-authors of Luis Tecedor

This figure shows the co-authorship network connecting the top 25 collaborators of Luis Tecedor. A scholar is included among the top collaborators of Luis Tecedor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis Tecedor. Luis Tecedor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yen‐Hsu, Luis Tecedor, Megan S. Keiser, et al.. (2025). Optimized AAV capsids for basal ganglia diseases show robust potency and distribution. Nature Communications. 16(1). 4653–4653.
2.
Tecedor, Luis, Yong Hong Chen, David E. Leib, et al.. (2025). An AAV variant selected through NHP screens robustly transduces the brain and drives secreted protein expression in NHPs and mice. Science Translational Medicine. 17(798). eadr2531–eadr2531. 1 indexed citations
3.
Jackson, Rosemary J., Megan S. Keiser, Soroush Hajizadeh, et al.. (2024). APOE2 gene therapy reduces amyloid deposition and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer disease. Molecular Therapy. 32(5). 1373–1386. 37 indexed citations
4.
Carrell, Ellie M., Yong Hong Chen, Paul T. Ranum, et al.. (2023). VWA3A-derived ependyma promoter drives increased therapeutic protein secretion into the CSF. Molecular Therapy — Nucleic Acids. 33. 296–304. 5 indexed citations
5.
Ahrens‐Nicklas, Rebecca C., Luis Tecedor, Richard J. Chung, et al.. (2022). Neuronal genetic rescue normalizes brain network dynamics in a lysosomal storage disorder despite persistent storage accumulation. Molecular Therapy. 30(7). 2464–2473. 8 indexed citations
6.
Monteys, Alex Mas, Paul T. Ranum, Luis Tecedor, et al.. (2021). Regulated control of gene therapies by drug-induced splicing. Nature. 596(7871). 291–295. 83 indexed citations
7.
Ahrens‐Nicklas, Rebecca C., et al.. (2019). Neuronal network dysfunction precedes storage and neurodegeneration in a lysosomal storage disorder. JCI Insight. 4(21). 14 indexed citations
8.
Chen, Yonghong, et al.. (2018). Overcoming Limitations Inherent in Sulfamidase to Improve Mucopolysaccharidosis IIIA Gene Therapy. Molecular Therapy. 26(4). 1118–1126. 13 indexed citations
9.
10.
Schultz, Mark L., et al.. (2018). Modulating membrane fluidity corrects Batten disease phenotypes in vitro and in vivo. Neurobiology of Disease. 115. 182–193. 23 indexed citations
11.
Ahrens‐Nicklas, Rebecca C., Luis Tecedor, Mark L. Schultz, et al.. (2017). Small molecule therapies for juvenile neuronal ceroid lipofuscinosis. Molecular Genetics and Metabolism. 120(1-2). S18–S19. 1 indexed citations
12.
Katz, Martin L., Luis Tecedor, Yonghong Chen, et al.. (2015). AAV gene transfer delays disease onset in a TPP1-deficient canine model of the late infantile form of Batten disease. Science Translational Medicine. 7(313). 313ra180–313ra180. 109 indexed citations
13.
Schultz, Mark L., Luis Tecedor, Colleen S. Stein, Mark A. Stamnes, & Beverly L. Davidson. (2014). CLN3 Deficient Cells Display Defects in the ARF1-Cdc42 Pathway and Actin-Dependent Events. PLoS ONE. 9(5). e96647–e96647. 20 indexed citations
14.
Lee, John H., Luis Tecedor, Yong Hong Chen, et al.. (2014). Reinstating Aberrant mTORC1 Activity in Huntington’s Disease Mice Improves Disease Phenotypes. Neuron. 85(2). 303–315. 122 indexed citations
15.
Tecedor, Luis, Colleen S. Stein, Mark L. Schultz, et al.. (2013). CLN3 Loss Disturbs Membrane Microdomain Properties and Protein Transport in Brain Endothelial Cells. Journal of Neuroscience. 33(46). 18065–18079. 53 indexed citations
16.
McLoughlin, Hayley S., Sarah K. Fineberg, Laboni Ghosh, Luis Tecedor, & Beverly L. Davidson. (2012). Dicer is required for proliferation, viability, migration and differentiation in corticoneurogenesis. Neuroscience. 223. 285–295. 57 indexed citations
17.
Schultz, Mark L., Luis Tecedor, Michael Chang, & Beverly L. Davidson. (2011). Clarifying lysosomal storage diseases. Trends in Neurosciences. 34(8). 401–410. 172 indexed citations
18.
Monteys, Alex Mas, Ryan M. Spengler, Ji Wan, et al.. (2010). Structure and activity of putative intronic miRNA promoters. RNA. 16(3). 495–505. 295 indexed citations
19.
Ding, Song‐Lin, Luis Tecedor, Colleen S. Stein, & Beverly L. Davidson. (2010). A knock-in reporter mouse model for Batten disease reveals predominant expression of Cln3 in visual, limbic and subcortical motor structures. Neurobiology of Disease. 41(2). 237–248. 14 indexed citations
20.
Eliason, Steven, Colleen S. Stein, Qinwen Mao, et al.. (2007). A Knock-In Reporter Model of Batten Disease. Journal of Neuroscience. 27(37). 9826–9834. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zofia M. Lasiecka Breakdown of academic impact, for papers by Xiaolu A. Cambronne Breakdown of academic impact, for papers by Zen Kouchi Breakdown of academic impact, for papers by Giorgio Rovelli Breakdown of academic impact, for papers by Tiago G. Santos Breakdown of academic impact, for papers by Laura Magri Breakdown of academic impact, for papers by Heather Flanagan‐Steet Breakdown of academic impact, for papers by Chang-Hyuk Kwon Breakdown of academic impact, for papers by Anita Schlierf Breakdown of academic impact, for papers by Sergi Simó
Rankless by CCL
2026